General Surgery Devices are used in diagnostic and surgical interventions primarily for the gastrointestinal tract, abdomen, and pelvis. Biopsy entails the removal of some tissue from the body for the purpose of diagnosis or for its examination under a microscope. GlobalData uses proprietary data and analytics to provide a comprehensive report on the biopsy devices devices market, including market shares of different players within the US. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the biopsy devices market in the US was Becton Dickinson and Co followed by Hologic, Boston Scientific, Argon Medical Devices, Merit Medical Systems, Olympus, Medtronic, Devicor Medical Products, Cook Medical, Integra LifeSciences, Teleflex, United States Endoscopy Group, ConMed, Acuderm and Henry Schein.
A Biopsy Device is an instrument that aids in the removal of tissue samples from the body. Biopsy Guns, Vacuum-Assisted Needle Devices, Biopsy Forceps, Biopsy Punches and Biopsy Needles are covered under Biopsy Device. Biopsy Needles are needles used to sample small amounts of tissues from the body. Vacuum-Assisted Needle Devices use a vacuum-powered system that aspirates several tissue samples rather than relying on the spring-loading mechanism seen in biopsy guns. Biopsy Forceps are used in association with an endoscope to obtain biopsy samples. Biopsy Guns are handheld spring-loaded devices with core needles attached. Biopsy Punches have a small circular blade attached to a handle which is rotated and moved down the layers of the tissue especially the skin to obtain a cylindrical tissue sample.
The value of the biopsy devices devices market within the US was expected to be over $400m in 2023.
For the latest complete market share analysis of biopsy devices device market in the US, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
